Withdrawal of antibiotic growth promoters from broiler diets: performance indexes and economic impact.

This study aimed to estimate the productive and economic impacts caused by the withdrawal of antibiotic growth promoters (AGP) from broilers diet. Indexed publications that compared diets with or without AGP (AGP+/AGP-) for broilers (from initial to final phase) were collected and the results of feed intake, weight gain, and feed conversion were compiled in a database. A meta-analysis was performed following sequential analyses: graphical approach (to observe biological data coherence), correlation (to identify related factors), and variance-covariance (to compare groups). The annual number of broiler slaughtered in Brazil, target weight gain and feed conversion for each phase, the variation in feed conversion, feed cost, and AGP costs were used to build a model to estimate the effects of the AGP withdrawal on feeding costs. The database comprised 174 scientific articles containing 183 experiments, totaling 121,643 broilers, most of which were Ross (52% of the studies). The most frequent AGP sources/forms in the database were Avilamycin (41% of the AGP+ treatments), Flavomycin (19%), Virginiamycin (16%), and Bacitracin (14%). Higher feed intake, weight gain, and lower feed conversion were attributed (P < 0.05) to AGP+ diets during Initial phase (1 to 21 D). In Final phase (22 to 42 D) no differences were observed in performance variables. Treatments AGP+ presented higher weight gain and better feed conversion in the Total period (1 to 42 D). The results of feed conversion were improved (P < 0.05) with Avilamycin and Flavomycin; Virginiamycin improved weight gain and feed conversion. In the Total period, the economic impact was $0.03 per animal and a total of $183,560,232 per year. It was concluded that broilers fed AGP+ diets have higher weight gain and better feed conversion than those fed AGP- diets, and withdrawing AGP increases production costs.

Performance comparison between broilers positive and negative for antibodies against the chicken anemia virus

The chicken anemia virus (CAV) is present in virtually every country investigated, Brazil including. The aim of this study was to determine what the difference in performance is between positive (progeny of breeders vaccinated or with natural infection) and negative broilers to the presence of antibodies against the CAV in currently intensive raising systems. As a result, it was observed that negative broilers were significantly heavier than positive broilers. Negative males had a final weight 5.43% higher than positive males. There was no significant difference among different treatments in relation to parameters as mortality and feeding conversion. These study indicated that the presence of antibodies against CAV in broilers - may it be through vaccination or natural infection of breeders - did not generate progeny with superior performance under the tested raising conditions.

O vírus da anemia das galinhas (CAV - "chicken anemia virus") está presente em praticamente todos os países investigados, inclusive no Brasil. O objetivo deste trabalho foi determinar qual a diferença de desempenho, comparando frangos positivos (progênie de matrizes vacinadas ou com infecção natural) com frangos negativos para a presença de anticorpos contra o CAV, no sistema atual de criação intensiva. Como resultado, foi observado que os frangos negativos foram significativamente mais pesados que os frangos positivos. Os machos negativos tiveram um peso final 5,43% superior ao dos machos positivos. Não houve diferença significativa entre os tratamentos em relação aos parâmetros de mortalidade e conversão alimentar. Este estudo indicou que a presença de anticorpos contra o CAV em frangos de corte, seja através da vacinação ou infecção natural das matrizes, não gerou uma progênie com melhor desempenho nas condições de criação testadas.